T. +31 649 998 203 | +34 944 008 847 ( IES Medical )

Schmidt et al. Flow-Controlled Ventilation Attenuates Lung Injury in a Porcine Model of Acute Respiratory Distress Syndrome: A Preclinical Randomized Controlled Study. Crit Care Med. 2020 Mar;48(3):e241-e248

This randomised controlled study by the workgroup of Prof. Schumann demonstrates an increased ventilation efficiency and lung protective effects by FCV compared to VCV in an experimental model of acute respiratory distress syndrome (ARDS). With similar PEEP, peak pressures, tidal volumes and respiratory rates FCV significantly improved oxygenation (PaO2 +47%, P=0.035), while using a 26% lower minute volume (P<0.001). In the dependent lung parts FCV resulted in more normally aerated lung tissue (24% vs 10%; P=0.004) and less non-aerated lung tissue (23% vs 38%; P=0.033) as compared to VCV. Furthermore, lung damage was reduced by FCV as shown by the presence of thinner alveolar walls (5.5 µm vs 7.8 µm; P<0.001), a reduced amount of infiltrating inflammatory cells (20/field vs 32/field; P<0.001), and a higher concentration of surfactant protein A in the bronchoalveolar lavage fluid (1.1 vs 1.0; P=0.039).

The authors state that they feel confident that their results “provide evidence for an attenuated lung injury after FCV.”

Get back to Literature

SEE OUR PRODUCTS

  • Tritube
  • Cricath
  • Evone
  • Ventrain

BLOG/NEWS

  • Evone is the best thing ever (read more..)
  • Ventrain is the greatest thing (read more..)
  • etc
  • etc

LITERATURE

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s,

CONTACT US

Ventinova Medical
Meerenakkerplein 7
5652 BJ Eindhoven (NL)

T. +31 (0)40 7516020
E. info@ventinova.nl